Showing 1 - 10 of 215
Researchers procured a range of antimalarial, antibiotic and antimycobacterial drugs from cities in six countries: Ghana, India, Kenya, Nigeria, Tanzania, and Uganda. Semi-quantitative thin-layer chromatography (TLC) and disintegration tests, Raman spectrometry, and near-infrared (NIR)...
Persistent link: https://www.econbiz.de/10014152650
Background: India is an increasingly influential player in the global pharmaceutical market. Key parts of the drug regulatory system are controlled by the states, each of which applies its own standards for enforcement, not always consistent with others. A pilot study was conducted in two major...
Persistent link: https://www.econbiz.de/10014045573
Background: The Affordable Medicines Facility – malaria (AMFm) is a subsidy mechanism to lower the price of, and hence increase access to, the best antimalarial medicines, artemisinin-based combination therapies (ACTs). While the AMFm stipulates that only quality-approved products are eligible...
Persistent link: https://www.econbiz.de/10014166199
This Health Policy Outlook assesses the market for chronic disease medications such as antiretroviral drugs (ARVs) to treat HIV/AIDS. A tiered, or differential, pricing structure serves public health by ensuring the greatest affordability of patented drugs as well as maximizing profits to the...
Persistent link: https://www.econbiz.de/10013034854
Persistent link: https://www.econbiz.de/10014439222
Persistent link: https://www.econbiz.de/10001689975
Persistent link: https://www.econbiz.de/10001574451
Phase 1 of the Affordable Medicines Facility for malaria (AMFm) is a $225 million initiative that was launched in 2010 in an effort to increase access to safe and effective artemisinin-based combination therapies (ACTs) by dramatically lowering their price with a global subsidy. The AMFm also...
Persistent link: https://www.econbiz.de/10013074073
Legal but poorly made, or substandard, drugs can be lethal. The problem is most prevalent in emerging markets, where gross flaws in production, especially by domestic producers selling only in local markets, are easily detected by simple quality-control tests. These problems will worsen as more...
Persistent link: https://www.econbiz.de/10013074076
In an effort to increase competition and decrease price, the Global Fund to Fight AIDS, Tuberculosis and Malaria recently began asking some grant recipients to use international competitive bidding processes for certain drug purchases. Unfortunately, for countries like Kenya, this request has...
Persistent link: https://www.econbiz.de/10013034874